These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 5511214)

  • 41. Succinic dehydrogenase in muscular dystrophy. An experimental study on secondary changes resulting from disturbance in neuromuscular integrity.
    Bajusz E
    Exp Med Surg; 1965; 23(2):169-76. PubMed ID: 5843911
    [No Abstract]   [Full Text] [Related]  

  • 42. Catecholamine distribution in mice afflicted with muscular dystrophy.
    Gordon P; Dowben RM
    Am J Physiol; 1966 Apr; 210(4):728-32. PubMed ID: 5906801
    [No Abstract]   [Full Text] [Related]  

  • 43. Muscle histochemistry in congenital muscular dystrophy with central nervous system involvement.
    Nonaka I; Sugita H; Takada K; Kumagai K
    Muscle Nerve; 1982 Feb; 5(2):102-6. PubMed ID: 6461828
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Amino acid plotting charts in progressive muscular dystrophy. Family studies].
    Beckmann R; Ritter H
    Dtsch Med Wochenschr; 1966 Dec; 91(52):2231-5. PubMed ID: 5926730
    [No Abstract]   [Full Text] [Related]  

  • 45. Storage and homoeostatic functions of the skeletal muscles in muscular dystrophy [proceedings].
    Daniel PM; Pratt OE; Spargo E
    J Physiol; 1978 Feb; 275():41P-42P. PubMed ID: 633135
    [No Abstract]   [Full Text] [Related]  

  • 46. Acetoacetate metabolism in muscle homogenates from normal and dystrophic mice.
    GOULD A; COLEMAN DL
    Arch Biochem Biophys; 1962 Feb; 96():408-11. PubMed ID: 13900811
    [No Abstract]   [Full Text] [Related]  

  • 47. [The treatment of progressive muscular dystrophy with nucleosides and nucleotides. Clinical and serologic findings (aldolase and creatinphosphokinase)].
    Ceccarelli A; Leone P; Moretti A
    Clin Pediatr (Bologna); 1967 Sep; 49(9):468-75. PubMed ID: 5608288
    [No Abstract]   [Full Text] [Related]  

  • 48. [Free amino acids and related ninhydrin-positive substances in the muscle in progressive muscular dystrophy].
    Yoshino Y; Mozai T
    Rinsho Shinkeigaku; 1973 Dec; 13(12):759-66. PubMed ID: 4799411
    [No Abstract]   [Full Text] [Related]  

  • 49. Duchenne muscular dystrophy: normal ATP turnover in cultured cells.
    Fox IH; Shefner R; Palmieri GM; Bertorini T
    Adv Exp Med Biol; 1986; 195 Pt B():493-9. PubMed ID: 3766238
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Maturational defect of regenerating muscle fibers in cases with Duchenne and congenital muscular dystrophies.
    Miike T
    Muscle Nerve; 1983 Oct; 6(8):545-52. PubMed ID: 6196637
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Therapeutic possibilities in progressive muscular dystrophy].
    Beckmann R; von Osten V
    Dtsch Med Wochenschr; 1966 Jan; 91(3):108-16. PubMed ID: 5901816
    [No Abstract]   [Full Text] [Related]  

  • 52. [The isoenzymes of lactate dehydrogenase and glutamic-oxalacetic transaminase in fetal and adult muscle and muscle of subjects affected by the Duchenne type of progressive muscular dystrophy].
    Mannucci PM; Idèo G; Cao A; Macciotta A
    Rass Med Sarda; 1965; 68(3):287-99. PubMed ID: 5844059
    [No Abstract]   [Full Text] [Related]  

  • 53. Organization of microtubules and microfilaments in fibroblasts in Duchenne muscular dystrophy muscle cultures.
    Walsh FS; Yasin R; Kundu K; Thompson EJ
    Ann Neurol; 1981 Feb; 9(2):202-4. PubMed ID: 7015994
    [No Abstract]   [Full Text] [Related]  

  • 54. [Changes in serum lipids in progressive muscular dystophy].
    Kunze D; Olthoff D; Schellnack K
    Dtsch Gesundheitsw; 1967 Dec; 22(51):2405-9. PubMed ID: 5614913
    [No Abstract]   [Full Text] [Related]  

  • 55. [Therapy of progressive muscular dystrophy].
    Beckmann R
    Med Klin; 1971 Aug; 66(32):1099. PubMed ID: 5562103
    [No Abstract]   [Full Text] [Related]  

  • 56. Isotachophoretic analysis of some compounds involved in energy metabolism in normal and pathological human muscle extracts.
    Brolsma MF; Oerlemans FT; Verburg MP; De Bruyn CH
    Adv Exp Med Biol; 1984; 165 Pt B():415-8. PubMed ID: 6720438
    [No Abstract]   [Full Text] [Related]  

  • 57. [Research on the composition of axillary venous blood during dynamic work of upper limb muscles in patients with muscular dystrophy].
    Contamin F; Dussart J; Duchon d'Engenières M
    Rev Neurol (Paris); 1967 Oct; 117(4):549-55. PubMed ID: 5609764
    [No Abstract]   [Full Text] [Related]  

  • 58. [Our experience in the treatment of progressive muscular dystrophy].
    Buscaino GA
    Acta Neurol (Napoli); 1966; 21(2):133-50. PubMed ID: 5961587
    [No Abstract]   [Full Text] [Related]  

  • 59. Abnormal polyamine metabolism in hereditary muscular dystrophies: effect of human growth hormone.
    Rudman D; Kutner MH; Chawla RK; Goldsmith MA
    J Clin Invest; 1980 Jan; 65(1):95-102. PubMed ID: 7350201
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Changes in protein and enzymes in muscular degeneration subsequent to denervation.
    FISCHER E
    Am J Phys Med; 1955 Feb; 34(1):212-22. PubMed ID: 14361693
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.